Type : |
Journal |
Internett-koblingen : |
https://doi.org/10.1515/pthp-2020-0013 |
|
Forskerteamet : |
Angers - University Hospital of Angers, Pharmacy Department |
Forfattere : |
Lebreton V, Bourcier B, Cosson K, Lagarce F, Spiesser-Robelet L, Vrignaud S. |
Tittel : |
New liquid oral formulations of hydroxychloroquine: a physicochemical stability study. |
Nummer : |
Pharmaceutical Technology in Hospital Pharmacy ; 6(1): 20200013. 2021 |
|
Nivå of Evidence : |
|
fysisk stabilitet : |
|
kjemisk stabilitet : |
|
andre metoder : |
|
Kommentarer : |
|
Lister
Hydroxychloroquine sulfate
|
![Antiinflammatorisk Antiinflammatorisk](./images/Picto.520.jpg) |
![Oppløsningsstabilitet Oppløsningsstabilitet](./images/Picto.591.jpg) |
![Glass Glass](./images/Picto.532.jpg) |
![Tabletter Tabletter](./images/Picto.10386.jpg) |
1500 mg Plaquenil® |
SyrSpend SF PH4® |
>> 30 mL |
|
2-8°C |
![Beskyttes mot lys Beskyttes mot lys](./images/Picto.526.jpg) |
90 |
![Dag Dag](./images/Picto.542.gif) |
|
|
![Oppløsningsstabilitet Oppløsningsstabilitet](./images/Picto.591.jpg) |
![Glass Glass](./images/Picto.532.jpg) |
![Tabletter Tabletter](./images/Picto.10386.jpg) |
1500 mg Plaquenil® |
OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
2-8°C |
![Beskyttes mot lys Beskyttes mot lys](./images/Picto.526.jpg) |
90 |
![Dag Dag](./images/Picto.542.gif) |
|
|
![Oppløsningsstabilitet Oppløsningsstabilitet](./images/Picto.591.jpg) |
![Glass Glass](./images/Picto.532.jpg) |
![Tabletter Tabletter](./images/Picto.10386.jpg) |
1500 mg Plaquenil® |
SyrSpend SF PH4® |
>> 30 mL |
|
28-32°C |
![Beskyttes mot lys Beskyttes mot lys](./images/Picto.526.jpg) |
60 |
![Dag Dag](./images/Picto.542.gif) |
|
|
![Oppløsningsstabilitet Oppløsningsstabilitet](./images/Picto.591.jpg) |
![Glass Glass](./images/Picto.532.jpg) |
![Tabletter Tabletter](./images/Picto.10386.jpg) |
1500 mg Plaquenil® |
OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
28-32°C |
![Beskyttes mot lys Beskyttes mot lys](./images/Picto.526.jpg) |
90 |
![Dag Dag](./images/Picto.542.gif) |
|
|
|
|